Skip to main content

Animations

MJFF Publications

8571 - 8580 of 8808 Results
Title
Year
  • Year
  • 2019
  • 2016
  • 2018
  • 2025
  • 2020
  • 2025
  • 2024
  • 2018
  • 2004
  • 2018
  • Summary Details
    RESTRICTED
    Title: Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide Standard
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00920
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0165964
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-018-1948-2
    Citation Count: 167
  • Summary Details
    RESTRICTED
    Title: Nutrition Effects on Brain Outcomes and Recovery in Stroke after Hospitalization (NOURISH): Randomized controlled trial protocol and rationale
    Journal Name: Contemporary Clinical Trials
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.cct.2025.108108
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.02.026
    Citation Count: 29
  • Summary Details
    OPEN
    Title: A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x251356503
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Thermodynamic characterization of amyloid polymorphism by microfluidic transient incomplete separation
    Journal Name: Chemical Science
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1039/d3sc05371g
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Neurite Collapse and Altered ER Ca2+ Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation
    Journal Name: Stem Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.stemcr.2018.11.021
    Citation Count: 72
  • Summary Details
    OPEN
    Title: BAG5 Inhibits Parkin and Enhances Dopaminergic Neuron Degeneration
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2004.11.026
    Citation Count: 196
  • Summary Details
    OPEN
    Title: Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0203659
    Citation Count: 70
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.